Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.06 -0.02 (-1.20%)
As of: Oct 22, 2026 · 10:13 AM EDT

Black Diamond Therapeutics (BDTX) Liabilities and Shareholders Equity (2018 - 2026)

Updated

Black Diamond Therapeutics' Liabilities and Shareholders Equity came in at $125.03 million for Q2 2026, down 24.9% from $166.39 million a year earlier and down 5.9% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Black Diamond Therapeutics' Liabilities and Shareholders Equity was $143.01 million, up 16.6% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -15.4% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $122.64 million in FY2024 (-22.7%), $158.57 million in FY2023 (+1.5%), $156.26 million in FY2022 (-36.9%) and $247.68 million in FY2021 (-24.9%).
  • The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q4 2024.
  • Year-over-year, Liabilities and Shareholders Equity increased in four of the last eight quarters, with an average decline of 3.3%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q2 2024 (growth of 25.1%), and the weakest in Q2 2023 (a decline of 39.7%).
  • Business Quant data shows BDTX's Liabilities and Shareholders Equity at $132.92 million (Q1 2026), $143.01 million (Q4 2025) and $157.73 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn 135.12 Bn
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn 115.83 Bn
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn 49.36 Bn
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn 201.13 Bn
10 Black Diamond Therapeutics 118.18 Mn -374.74 Mn - 125.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 125.03 Mn
Mar 31, 2026 132.92 Mn
Dec 31, 2025 143.01 Mn
Sep 30, 2025 157.73 Mn
Jun 30, 2025 166.39 Mn
Mar 31, 2025 176.25 Mn
Dec 31, 2024 122.64 Mn
Sep 30, 2024 137.90 Mn
Jun 30, 2024 149.99 Mn
Mar 31, 2024 142.52 Mn
Dec 31, 2023 158.57 Mn
Sep 30, 2023 172.38 Mn
Jun 30, 2023 119.88 Mn
Mar 31, 2023 135.58 Mn
Dec 31, 2022 156.26 Mn
Sep 30, 2022 180.42 Mn
Jun 30, 2022 198.83 Mn
Mar 31, 2022 219.48 Mn
Dec 31, 2021 247.68 Mn
Sep 30, 2021 274.13 Mn
API Access

Black Diamond Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BDTX&period=max&api_key=YOUR_API_KEY